C49 -Malignant neoplasm of other connective and soft tissue
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C49 – N =7,909
| Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
| 1982 | 32.3% | 14.7% | 5.6% | 15.5% | 31.9% | 232 |
| 1983 | 26% | 19.1% | 6% | 14.9% | 34% | 215 |
| 1984 | 21.8% | 17.1% | 16.6% | 15.5% | 29% | 193 |
| 1985 | 22% | 14.6% | 10.7% | 15.1% | 37.6% | 205 |
| 1986 | 22.9% | 18.4% | 9.4% | 19.3% | 30% | 223 |
| 1987 | 21.9% | 16.9% | 8.9% | 15.2% | 37.1% | 237 |
| 1988 | 25% | 15.2% | 11.9% | 19.3% | 28.7% | 244 |
| 1989 | 29.6% | 12.1% | 13.6% | 11.1% | 33.7% | 199 |
| 1990 | 24.7% | 14.3% | 13.9% | 17% | 30% | 223 |
| 1991 | 27.8% | 15.4% | 12.3% | 15.4% | 29.1% | 227 |
| 1992 | 22.8% | 10.3% | 6.7% | 12.9% | 47.3% | 224 |
| 1993 | 27.1% | 11.6% | 8% | 17.1% | 36.3% | 251 |
| 1994 | 19.4% | 21% | 10.8% | 12.9% | 36% | 186 |
| 1995 | 34% | 19.6% | 10% | 12% | 24.4% | 209 |
| 1996 | 35.4% | 13.3% | 8.2% | 14.9% | 28.2% | 195 |
| 1997 | 28.1% | 16.2% | 14% | 7.7% | 34% | 235 |
| 1998 | 24.9% | 13.3% | 11.2% | 14.2% | 36.5% | 233 |
| 1999 | 31.3% | 10% | 7% | 13.4% | 38.3% | 201 |
| 2000 | 29.5% | 18.4% | 8.8% | 5.1% | 38.2% | 217 |
| 2001 | 27.7% | 17.8% | 7.9% | 9.5% | 37.2% | 253 |
| 2002 | 28% | 18.8% | 9.6% | 13% | 30.5% | 239 |
| 2003 | 22.8% | 16.2% | 6.6% | 16.2% | 38.2% | 259 |
| 2004 | 21.8% | 18.5% | 8.5% | 18.1% | 33.1% | 248 |
| 2005 | 35.1% | 18.5% | 4% | 14.1% | 28.2% | 248 |
| 2006 | 33.1% | 18.1% | 5% | 11.9% | 31.9% | 260 |
| 2007 | 30.3% | 15.1% | 4% | 12.7% | 37.8% | 251 |
| 2008 | 28.3% | 16.7% | 7.2% | 22.7% | 25.1% | 251 |
| 2009 | 30.3% | 18.1% | 8.1% | 15.9% | 27.7% | 271 |
| 2010 | 35.8% | 15.5% | 7.2% | 17.7% | 23.8% | 265 |
| 2011 | 22.3% | 7.8% | 6% | 11.7% | 52.1% | 282 |
| 2012 | 14.5% | 9% | 8.7% | 5.9% | 61.9% | 289 |
| 2013 | 23.1% | 7.7% | 5.6% | 8% | 55.5% | 337 |
| 2014 | 19.5% | 5.9% | 7.2% | 9.1% | 58.3% | 307 |